German Medtech Faces 2026 In Better Shape Vs Economic and Operational Pressures

EU MDR Remains Biggest Hurdle For Medtech

 
• By Ashley Yeo
  
Medtechs attended the strategy dialog at the federal chancellery (Shutterstock)

More from Policy & Regulation

More from Medtech Insight